Patents by Inventor Abhijit Saha

Abhijit Saha has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20200253870
    Abstract: Present invention relates to a formulation from natural product. The formulation is LDV liposomal formulation of Photo System-I (PSI) which causes apoptotic death of cancer cells through ROS generation and a simple way for targeted delivery of the said formulation specifically to melanoma cancer cell. LDV liposomal formulation of PSI was prepared for targeted delivery to melanoma cancer cell. Through this targeted delivery inventors have shown that LDV liposomal formulation of PSI specifically kills melanoma cancer cells leaving normal cells unaffected. The present invention elucidates that LDV liposomal formulation of PSI is more potent anti-cancer agent than doxorubicin for melanoma.
    Type: Application
    Filed: September 16, 2017
    Publication date: August 13, 2020
    Inventors: Surajit GHOSH, Abhijit SAHA, Subhajit GHOSH, Saswat MOHAPATRA, Batakrishna JANA, Debmalya BHUNIA
  • Patent number: 10738297
    Abstract: Hydrogel compositions including a polymer uniformly embedded with a loading agent are provided. Also provided are methods for extrusion printing hydrogel compositions to provide extruded hydrogel compositions, which can be crosslinked to provide crosslinked hydrogel structures. Also provided are methods for using crosslinked hydrogel structures in chemical processes.
    Type: Grant
    Filed: May 12, 2017
    Date of Patent: August 11, 2020
    Assignee: University of Washington
    Inventors: Rose Ann Cattolico, Chloe Ramos Deodato, Alshakim Nelson, Robert Jun Ono, Abhijit Saha, Trevor Gerald Johnston, Dylan Gary Karis
  • Patent number: 10100082
    Abstract: The present investigation involves designing of a novel hexapeptide, which spontaneously self-assembles to form nanovesicles in physiological conditions. This peptide not only strongly binds with ?-tubulin near taxol binding site, but also binds with microtubule lattice in-vitro, as well as intracellular microtubule networks. Interestingly, it inhibits amyloid fibril formation upon co-incubation with A? peptide in-vitro and shows excellent neuroprotection against A? infected neuronal cell (PC12). Present invention provides a novel approach to produce a peptide-based therapeutics for neurodegenerative disease.
    Type: Grant
    Filed: March 7, 2016
    Date of Patent: October 16, 2018
    Assignee: Council of Scientific and Industrial Research
    Inventors: Surajit Ghosh, Atanu Biswas, Batakrishna Jana, Saswat Mohapatra, Subhas Chandra Biswas, Suraiya Saleem, Prasenjit Mondal, Anindyasundar Adak, Subhajit Ghosh, Abhijit Saha, Debmalya Bhunia
  • Publication number: 20170327813
    Abstract: Hydrogel compositions including a polymer uniformly embedded with a loading agent are provided. Also provided are methods for extrusion printing hydrogel compositions to provide extruded hydrogel compositions, which can be crosslinked to provide crosslinked hydrogel structures. Also provided are methods for using crosslinked hydrogel structures in chemical processes.
    Type: Application
    Filed: May 12, 2017
    Publication date: November 16, 2017
    Inventors: Rose Ann Cattolico, Chloe Ramos Deodato, Alshakim Nelson, Robert Jun Ono, Abhijit Saha, Trevor Gerald Johnston, Dylan Gary Karis
  • Publication number: 20170253631
    Abstract: The present investigation involves designing of a novel hexapeptide, which spontaneously self-assembles to form nanovesicles in physiological conditions. This peptide not only strongly binds with ?-tubulin near taxol binding site, but also binds with microtubule lattice in-vitro, as well as intracellular microtubule networks. Interestingly, it inhibits amyloid fibril formation upon co-incubation with A? peptide in-vitro and shows excellent neuroprotection against A? infected neuronal cell (PC12). Present invention provides a novel approach to produce a peptide-based therapeutics for neurodegenerative disease.
    Type: Application
    Filed: March 7, 2016
    Publication date: September 7, 2017
    Inventors: Surajit Ghosh, Atanu Biswas, Batakrishna Jana, Saswat Mohapatra, Subhas Chandra Biswas, Suraiya Saleem, Prasenjit Mondal, Anindyasundar Adak, Subhajit Ghosh, Abhijit Saha, Debmalya Bhunia
  • Patent number: 7991744
    Abstract: A system and method for checkpoint tuning in a computer environment comprising a processor coupled to a statistical database and at least one database or table manager and data log files. The data log files store data relating to the operations of the database or table manager. The processor executes a module that captures data comprising the number of operations, the time taken by the checkpoint process, folded journal entries, long running transactions, and the ratio of WRITE:READ operations. The processor then stores the captured data and processes the collected data, generating statistics therefrom. The statistical data is stored in the statistical database. The system selects checkpoint intervals based on the data statistics; and implements the checkpoint intervals.
    Type: Grant
    Filed: July 10, 2008
    Date of Patent: August 2, 2011
    Assignee: International Business Machines Corporation
    Inventors: Abhijit Saha, Sudip Bhowmik
  • Publication number: 20100011026
    Abstract: A system and method for checkpoint tuning in a computer environment comprising a processor coupled to a statistical database and at least one database or table manager and data log files. The data log files store data relating to the operations of the database or table manager. The processor executes a module that captures data comprising the number of operations, the time taken by the checkpoint process, folded journal entries, long running transactions, and the ratio of WRITE:READ operations. The processor then stores the captured data and processes the collected data, generating statistics therefrom. The statistical data is stored in the statistical database. The system selects checkpoint intervals based on the data statistics; and implements the checkpoint intervals.
    Type: Application
    Filed: July 10, 2008
    Publication date: January 14, 2010
    Applicant: INTERNATIONAL BUSINESS MACHINES CORPORATION
    Inventors: Abhijit Saha, Sudip Bhowmik